<p>Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III&ndash;IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus</p>Qian Zhao, Mingzhi Zhang, Shanshan Fan et al.|Cancer Management and Research|2019Cited by 20
<p>Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with <em>MYC</em>, <em>BCL2/BCL6</em> gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study</p>Qianwen Ma, Lei Zhang, Yu Chang et al.|Cancer Management and Research|2019Cited by 11
Cost-effectiveness of zanubrutinib versus ibrutinib in adult patients with Waldenström macroglobulinemia in the United States.Jorge J. Castillo, Boxiong Tang, Xīn Gào et al.|Journal of Clinical Oncology|2021Cited by 6
Efficacy and safety of zanubrutinib versus rituximab-based chemoimmunotherapy in Waldenström macroglobulinemia (WM): Matching-adjusted indirect comparisons.Jorge J. Castillo, Boxiong Tang, Keri Yang et al.|Journal of Clinical Oncology|2021Cited by 2